Clinical Research Directory
Browse clinical research sites, groups, and studies.
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Sponsor: Alexion Pharmaceuticals, Inc.
Summary
Long-term, multicenter, multinational, observational, registry of patients with AQP4+ NMOSD that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapies (C5IT). The registry will also collect data on patient reported outcomes (PROs), quality of life (QoL), and targeted AQP4+ NMOSD therapies used to provide evidence on the real-world impact of ALXN-C5IT on patients with AQP4+ NMOSD.
Official title: A Long-Term, Prospective, Observational, Registry of Patients With Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated With Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
122
Start Date
2024-02-01
Completion Date
2030-03-01
Last Updated
2026-02-10
Healthy Volunteers
No
Locations (33)
Clinical Trial Site
Washington D.C., District of Columbia, United States
Research Site
Boston, Massachusetts, United States
Clinical Trial Site
Chapel Hill, North Carolina, United States
Clinical Trial Site
Columbus, Ohio, United States
Clinical Trial Site
Plano, Texas, United States
Clinical Trial Site
Milwaukee, Wisconsin, United States
Clinical Trial Site
Buenos Aires, Argentina
Clinical Trial Site
Buenos Aires, Argentina
Clinical Trial Site
Buenos Aires, Argentina
Clinical Trial Site
Buenos Aires, Argentina
Clinical Trial Site
Burnaby, British Columbia, Canada
Clinical Trial Site
Beijing, China
Clinical Trial Site
Guangzhou, China
Clinical Trial Site
Henan, China
Clinical Trial Site
Shanghai, China
Clinical Trial Site
Sichuan, China
Clinical Trial Site
Wuhan, China
Clinical Trial Site
Dresden, Germany
Clinical Trial Site
Essen, Germany
Clinical Trial Site
München, Germany
Clinical Trial Site
Naples, Italy
Clinical Trial Site
Fukuoka, Japan
Clinical Trial Site
Kawasaki, Japan
Clinical Trial Site
Miyagi, Japan
Clinical Trial Site
Tokyo, Japan
Clinical Trial Site
Daejeon, South Korea
Clinical Trial Site
Gyeonggi-do, South Korea
Clinical Trial Site
Seoul, South Korea
Clinical Trial Site
Seoul, South Korea
Clinical Trial Site
Seoul, South Korea
Clinical Trial Site
Seoul, South Korea
Clinical Trial Site
Seoul, South Korea
Clinical Trial Site
Seoul, South Korea